Tofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation Study

NCT06310057 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Axial Spondyloarthritis

Interventions

DRUG: Tofacitinib

Sponsor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Collaborators

[object Object]